Pharmaceuticals stocks
1,392 listed pharmaceuticals companies, ordered by market capitalisation, inside the Health Care sector. Every one has a free page with its price history, key figures and Tweenvest factor scores.
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.04T | $1,212.00 | +3.90% |
| Johnson & JohnsonNYSE: JNJ | $599.12B | $253.54 | +1.98% |
| Merck & Co., Inc.NYSE: MRK | $350.29B | $147.35 | +3.78% |
| Roche Holding AGSWX: ROP | $345.40B | CHF370.90 | +3.09% |
| Novartis AGSWX: NOVN | $272.34B | CHF119.30 | -0.55% |
| AstraZeneca PLCLSE: AZN | $244.42B | £123.00 | +3.40% |
| Novo Nordisk A/SCPSE: NOVO B | $169.97B | Dkr256.65 | +0.10% |
| Pfizer Inc.NYSE: PFE | $161.70B | $29.32 | +3.35% |
| Bristol-Myers Squibb CompanyNYSE: BMY | $115.76B | $59.06 | +4.22% |
| SanofiENXTPA: SAN | $94.87B | €71.82 | +1.53% |
| GSK plcLSE: GSK | $93.05B | £18.16 | +3.59% |
| Merck KGaAXTRA: MRK | $66.97B | €141.90 | +3.13% |
| Chugai Pharmaceutical Co., Ltd.TSE: 4519 | $64.08B | ¥6,170.00 | +2.51% |
| Takeda Pharmaceutical Company LimitedTSE: 4502 | $60.11B | ¥5,963.00 | +2.05% |
| Bayer AktiengesellschaftXTRA: BAYN | $48.55B | €45.07 | +2.08% |
| Teva Pharmaceutical Industries LimitedNYSE: TEVA | $48.07B | $41.22 | -0.07% |
| Galderma Group AGSWX: GALD | $46.87B | CHF171.85 | +2.69% |
| Jiangsu Hengrui Pharmaceuticals Co.,LtdSHSE: 600276 | $44.79B | CN¥45.51 | -1.17% |
| Sun Pharmaceutical Industries LimitedNSEI: SUNPHARMA | $44.76B | Rs1,770.70 | +0.61% |
| UCB SAENXTBR: UCB | $42.24B | €202.00 | +2.07% |
| Haleon plcLSE: HLN | $41.44B | £3.55 | +0.08% |
| Otsuka Holdings Co., Ltd.TSE: 4578 | $38.82B | ¥11,705.00 | +0.34% |
| Sandoz Group AGSWX: SDZ | $37.23B | CHF73.82 | +3.04% |
| Zoetis Inc.NYSE: ZTS | $30.70B | $75.55 | +1.68% |
| Daiichi Sankyo Company, LimitedTSE: 4568 | $30.29B | ¥2,636.00 | +0.50% |
| Astellas Pharma Inc.TSE: 4503 | $26.04B | ¥2,300.50 | +2.36% |
| Royalty Pharma plcNasdaqGS: RPRX | $25.19B | $58.84 | +4.01% |
| Hansoh Pharmaceutical Group Company LimitedSEHK: 3692 | $24.36B | HK$31.54 | -0.06% |
| Viatris Inc.NasdaqGS: VTRS | $19.81B | $17.59 | +1.97% |
| Torrent Pharmaceuticals LimitedBSE: 500420 | $18.31B | Rs4,660.00 | -2.14% |
| Shionogi & Co., Ltd.TSE: 4507 | $15.12B | ¥2,814.50 | +2.55% |
| Sichuan Biokin Pharmaceutical Co.,Ltd.SHSE: 688506 | $14.14B | CN¥229.33 | -5.24% |
| Yunnan Baiyao Group Co.,LtdSZSE: 000538 | $13.69B | CN¥51.40 | +1.90% |
| Jazz Pharmaceuticals plcNasdaqGS: JAZZ | $13.66B | $210.67 | +0.13% |
| CSPC Pharmaceutical Group LimitedSEHK: 1093 | $13.19B | HK$9.07 | +0.44% |
| Ipsen S.A.ENXTPA: IPN | $13.09B | €145.60 | +2.10% |
| Orion OyjHLSE: ORNBV | $12.98B | €86.35 | +4.35% |
| Corcept Therapeutics IncorporatedNasdaqCM: CORT | $12.73B | $118.92 | +0.95% |
| Sino Biopharmaceutical LimitedSEHK: 1177 | $12.14B | HK$5.35 | -0.93% |
| Recordati Industria Chimica e Farmaceutica S.p.A.BIT: REC | $12.14B | €53.00 | +0.09% |
| Zydus Lifesciences LimitedNSEI: ZYDUSLIFE | $11.52B | Rs1,117.50 | -2.46% |
| Laurus Labs LimitedNSEI: LAURUSLABS | $11.37B | Rs2,036.60 | +2.65% |
| Elanco Animal Health IncorporatedNYSE: ELAN | $11.20B | $22.50 | +0.40% |
| Dr. Reddy's Laboratories LimitedBSE: 500124 | $10.88B | Rs1,239.65 | +0.74% |
| Cipla LimitedNSEI: CIPLA | $10.86B | Rs1,301.00 | -3.20% |
| Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.SHSE: 600436 | $10.80B | CN¥119.84 | -0.71% |
| Mankind Pharma LimitedNSEI: MANKIND | $10.11B | Rs2,368.50 | -6.57% |
| Haisco Pharmaceutical Group Co., Ltd.SZSE: 002653 | $10.11B | CN¥61.02 | -1.87% |
| Aurobindo Pharma LimitedNSEI: AUROPHARMA | $10.07B | Rs1,693.00 | +0.97% |
| CSPC Innovation Pharmaceutical Co., Ltd.SZSE: 300765 | $9.44B | CN¥45.40 | -3.79% |
| Sichuan Kelun Pharmaceutical Co., Ltd.SZSE: 002422 | $9.43B | CN¥39.72 | -2.77% |
| Asymchem Laboratories (Tianjin) Co., Ltd.SZSE: 002821 | $9.36B | CN¥177.93 | -5.67% |
| Lupin LimitedBSE: 500257 | $9.26B | Rs1,960.00 | -3.40% |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd.SHSE: 600196 | $8.72B | CN¥23.89 | -0.54% |
| Krka, d. d.LJSE: KRKG | $8.71B | €257.00 | -0.39% |
| Financière de Tubize SAENXTBR: TUB | $8.49B | €170.40 | -1.56% |
| Eisai Co., Ltd.TSE: 4523 | $8.28B | ¥4,655.00 | +1.13% |
| Axsome Therapeutics, Inc.NasdaqGM: AXSM | $8.19B | $162.44 | +3.92% |
| ALK-Abelló A/SCPSE: ALK B | $7.56B | Dkr226.00 | -0.62% |
| Kyowa Kirin Co., Ltd.TSE: 4151 | $7.46B | ¥2,257.50 | +1.57% |
| H. Lundbeck A/SCPSE: HLUN B | $6.88B | Dkr47.48 | +1.19% |
| Gedeon Richter PLCBUSE: RICHTER | $6.87B | Ft12,250.00 | -0.81% |
| Amneal Pharmaceuticals, Inc.NasdaqGS: AMRX | $6.82B | $19.21 | -1.84% |
| Ono Pharmaceutical Co., Ltd.TSE: 4528 | $6.81B | ¥2,297.00 | +1.68% |
| Glenmark Pharmaceuticals LimitedNSEI: GLENMARK | $6.69B | Rs2,293.00 | -1.63% |
| Alkem Laboratories LimitedNSEI: ALKEM | $6.52B | Rs5,279.00 | +1.13% |
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.SZSE: 000999 | $6.26B | CN¥25.17 | -0.44% |
| Belite Bio, IncNasdaqCM: BLTE | $6.22B | $152.50 | -1.29% |
| Ligand Pharmaceuticals IncorporatedNasdaqGM: LGND | $6.02B | $297.11 | -1.56% |
| Abbott India LimitedBSE: 500488 | $5.71B | Rs25,999.85 | -3.10% |
| Veradermics, IncorporatedNYSE: MANE | $5.47B | $113.58 | -13.23% |
| Shanghai Allist Pharmaceuticals Co., Ltd.SHSE: 688578 | $5.26B | CN¥78.30 | +1.50% |
| Gland Pharma LimitedNSEI: GLAND | $5.22B | Rs3,061.80 | +6.52% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd.SZSE: 002294 | $5.12B | CN¥30.93 | +0.88% |
| Ipca Laboratories LimitedNSEI: IPCALAB | $5.02B | Rs1,915.40 | -1.43% |
| Beijing Tongrentang Co., LtdSHSE: 600085 | $4.97B | CN¥24.28 | +2.27% |
| Humanwell Healthcare (Group) Co.,Ltd.SHSE: 600079 | $4.69B | CN¥19.23 | +0.31% |
| Definium Therapeutics, Inc.NasdaqGS: DFTX | $4.62B | $34.08 | -0.87% |
| Hanmi Pharm. Co., Ltd.KOSE: A128940 | $4.54B | ₩480,500.00 | -5.04% |
| Sumitomo Pharma Co., Ltd.TSE: 4506 | $4.51B | ¥1,591.50 | -1.36% |
| Dong-E-E-Jiao Co., Ltd.SZSE: 000423 | $4.50B | CN¥47.19 | +0.62% |
| GlaxoSmithKline Pharmaceuticals LimitedBSE: 500660 | $4.45B | Rs2,539.80 | -8.46% |
| Ajanta Pharma LimitedNSEI: AJANTPHARM | $4.40B | Rs3,410.10 | -4.77% |
| Hikma Pharmaceuticals PLCLSE: HIK | $4.39B | £16.02 | +1.01% |
| Apeloa Pharmaceutical Co.,LtdSZSE: 000739 | $4.27B | CN¥25.40 | -8.44% |
| Dottikon ES Holding AGSWX: DESN | $4.27B | CHF263.00 | +2.33% |
| Aspen Pharmacare Holdings LimitedJSE: APN | $4.25B | R158.26 | -1.09% |
| Sam Chun Dang Pharm. Co., LtdKOSDAQ: A000250 | $4.24B | ₩243,500.00 | +17.63% |
| SK Biopharmaceuticals Co., Ltd.KOSE: A326030 | $4.23B | ₩72,700.00 | -4.09% |
| Changchun High-Tech Industry (Group) Co., Ltd.SZSE: 000661 | $4.21B | CN¥70.14 | -1.21% |
| Indivior Pharmaceuticals, Inc.NasdaqGS: INDV | $4.18B | $34.63 | -2.23% |
| Yuhan CorporationKOSE: A000100 | $4.06B | ₩73,100.00 | -1.35% |
| J. B. Chemicals & Pharmaceuticals LimitedBSE: 506943 | $4.02B | Rs— | — |
| Edgewise Therapeutics, Inc.NasdaqGS: EWTX | $3.94B | $37.36 | +2.98% |
| Zhejiang Huahai Pharmaceutical Co., Ltd.SHSE: 600521 | $3.88B | CN¥17.45 | +6.79% |
| Shijiazhuang Yiling Pharmaceutical Co., Ltd.SZSE: 002603 | $3.87B | CN¥15.53 | +1.17% |
| Camurus AB (publ)OM: CAMX | $3.81B | Skr635.00 | -0.94% |
| Caliway Biopharmaceuticals Co., Ltd.TWSE: 6919 | $3.77B | NT$77.50 | -3.00% |
| Hubei Jumpcan Pharmaceutical Co., Ltd.SHSE: 600566 | $3.75B | CN¥27.26 | +0.96% |
| Hypera S.A.BOVESPA: HYPE3 | $3.66B | R$26.00 | -3.45% |